Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Interprofessional Health Needs Assessment (IHNA) for Older Adults Living at Home (Impact-INHA)

6 de julio de 2026 actualizado por: Marianne Storm, University of Stavanger

Implementing and Evaluating the Impact of Interprofessional Health Needs Assessment (INHA) for Older Adults Living at Home

This randomized controlled trial aims to evaluate the effectiveness and cost-effectiveness of the Interprofessional Health Needs Assessment (IHNA) in older adults living at home. Specifically, the trial will assess the effects of IHNA on health-related quality of life, social care-related quality of life, survival, and health service utilization.

The primary objective is to determine the effect of IHNA on participants' health-related quality of life at 12 months. Secondary objectives are to assess its effects on social care-related quality of life, survival (time to death), health service utilization, and quality-adjusted life years (QALYs) at 6 and 12 months.

Descripción general del estudio

Descripción detallada

Early identification of health needs among home-dwelling elderly adults is crucial for maintaining health and function, improving quality of life, and preventing hospitalizations. When allocating municipal health and care services, healthcare professionals assess functional abilities and health needs. Based on this assessment, services such as emergency alarms, everyday rehabilitation, home nursing care, practical assistance at home, and assistive devices are assigned. However, there is no standardized approach to what should be included in these assessments or how they should be conducted.

This project develops a procedure for interprofessional health needs assessment (IHNA) to systematically identify and address the health needs of older adults living at home. IHNA integrates the older adult's values and preferences into the assessment, ensuring that interventions and services align with their priorities. IHNA incorporates screening tools to provide a structured, holistic assessment of health and social domains.

The project involves co-creation of IHNA with healthcare professionals and older adults, workplace training in the effective use of IHNA, and implementation in two Norwegian municipalities through a randomized controlled trial.

By developing interprofessional practices for assessing health needs and equipping healthcare professionals with screening tools and training, the project will help municipalities provide fairer, more effective services to home-dwelling older adults.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

200

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Arnt Egil Ydstebø

Ubicaciones de estudio

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto Mayor

Acepta Voluntarios Saludables

No

Descripción

Inclusion Criteria:

  • 65 years and older
  • applying for a municipal health and care service at home (i.e., practical assistance, home nursing, assistive devices, rehabilitation, day care center)
  • the health care service will have a duration of more than 2 weeks

Exclusion Criteria:

  • younger than 65 years
  • diagnosed with dementia
  • life expectancy shorter than 6 months
  • applying for a nursing home placement

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Investigación de servicios de salud
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Doble

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: INHA Intervention group
The intervention group will be assessed using INHA

Interprofessional teams with a nurse, physiotherapist, or occupational therapist from Stavanger and Sandnes municipalities will assess participants in the intervention group using the Interprofessional Health Needs Assessment (INHA) procedure. INHA includes screening tools to assess mobility, cognition, mental health, nutrition and oral health, vision and hearing, activities of daily living, social network, physical and behavioral health.

Based on the IHNA findings, the interprofessional teams, in collaboration with the older adult, will decide on the allocation of municipal health services, make referrals, and provide advice on available preventive and health promotion interventions from the municipality's health and care services and relevant voluntary and private actors.

Sin intervención: Control group
The participants in the control group will be assessed by the standard assessment form used by the municipality and have services allocated as usual.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Health-related quality of life
Periodo de tiempo: Baseline, 6 months and 12 months
Health-related quality of life will be assessed using the EuroQol 5-Dimension 5-Level questionnaire (EQ-5D-5L). The EQ-5D-5L descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five response levels: no problems, slight problems, moderate problems, severe problems, and extreme problems/unable to perform. Responses are combined into a 5-digit health-state profile, with 11111 representing the best health state and 55555 the worst health state. Health state will be converted into a utility index score, with higher scores indicating better health-related quality of life. The primary outcome will be the change in EQ-5D-5L utility index score from baseline to 12 months.
Baseline, 6 months and 12 months

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Self-rated health
Periodo de tiempo: Baseline, 6 months, and 12 months

The EuroQol Visual Analog Scale (EQ VAS) will be assessed as a secondary outcome measure of self-rated health. Participants rate their current health on a scale from 0 to 100.

A score of 100 is equivalent to the best possible health. A score of 0 is equivalent to the worst possible health. Changes in EQ VAS scores from baseline to 6 months and 12 months will be evaluated, with higher scores indicating better perceived health.

Baseline, 6 months, and 12 months
Social care related quality of life
Periodo de tiempo: Baseline, 6 months, and 12 months
The Adult Social Care Outcomes Toolkit (ASCOT) will be used as a secondary outcome measure of social care-related quality of life. ASCOT covers eight domains: control over daily life, personal cleanliness and comfort, food and drink, personal safety, social participation and involvement, occupation, accommodation cleanliness and comfort, and dignity. Each domain has four response options scored from 0 to 3, with higher scores indicating better outcomes. Domain responses will be combined into an overall ASCOT score, with higher scores indicating better social care-related quality of life. Changes in ASCOT scores from baseline to 6 months and 12 months will be evaluated.
Baseline, 6 months, and 12 months
Time to death (survival)
Periodo de tiempo: Baseline to 12 months
Time from baseline to death within 12 months will be obtained from municipal electronic patient records. Longer survival indicates a better outcome.
Baseline to 12 months
Health care utilization
Periodo de tiempo: 6 and 12 months
Health care utilization will be assessed as a secondary outcome measure. Data on nursing home admissions, municipal emergency service visits, and hospital admissions will be obtained from the Norwegian Registry for Primary Health Care and the Norwegian Patient Registry. Health care utilization will be measured as the number of nursing home admissions, municipal emergency service visits, and hospital admissions during the 6- and 12-month follow-up periods. Lower health care utilization indicates better outcomes.
6 and 12 months
Quality-Adjusted Life Years ( QALYs)
Periodo de tiempo: Baseline, 6 months and 12 months
Quality-Adjusted Life Years (QALYs) will be a secondary outcome, measuring the combined effects of the intervention on survival and health-related quality of life. QALYs will be calculated over the 12-month follow-up period by combining survival with health utility values derived from the EQ-5D. Higher QALYs indicate better overall health outcomes. QALY estimates will be used to inform cost-effectiveness analyses.
Baseline, 6 months and 12 months

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

10 de marzo de 2026

Finalización primaria (Estimado)

31 de diciembre de 2028

Finalización del estudio (Estimado)

30 de junio de 2029

Fechas de registro del estudio

Enviado por primera vez

17 de junio de 2026

Primero enviado que cumplió con los criterios de control de calidad

2 de julio de 2026

Publicado por primera vez (Actual)

7 de julio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

8 de julio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

6 de julio de 2026

Última verificación

1 de julio de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • 355225 (Otro número de subvención/financiamiento: The Research Council Of Norway)

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

INDECISO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir